The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer.
Sreekumar R, Al-Saihati H, Emaduddin M, Moutasim K, Mellone M, Patel A, Kilic S, Cetin M, Erdemir S, Navio MS, Lopez MA, Curtis N, Yagci T, Primrose JN, Price BD, Berx G, Thomas GJ, Tulchinsky E, Mirnezami A, Sayan AE.
Sreekumar R, et al. Among authors: cetin m.
Mol Oncol. 2021 Aug;15(8):2065-2083. doi: 10.1002/1878-0261.12965. Epub 2021 May 1.
Mol Oncol. 2021.
PMID: 33931939
Free PMC article.